| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72162-2420-3 | 72162-2420 | HUMAN PRESCRIPTION DRUG | TAZAROTENE | tazarotene | CREAM | TOPICAL | 20241111 | N/A | ANDA | ANDA217075 | Bryant Ranch Prepack | TAZAROTENE | .5 mg/g | 1 TUBE in 1 CARTON (72162-2420-3) / 30 g in 1 TUBE |
| 72162-2420-6 | 72162-2420 | HUMAN PRESCRIPTION DRUG | TAZAROTENE | tazarotene | CREAM | TOPICAL | 20241111 | N/A | ANDA | ANDA217075 | Bryant Ranch Prepack | TAZAROTENE | .5 mg/g | 1 TUBE in 1 CARTON (72162-2420-6) / 60 g in 1 TUBE |
| 45802-706-94 | 45802-706 | HUMAN PRESCRIPTION DRUG | TAZAROTENE | tazarotene | CREAM | TOPICAL | 20240909 | N/A | ANDA | ANDA217075 | Padagis Israel Pharmaceuticals Ltd | TAZAROTENE | .5 mg/g | 1 TUBE in 1 CARTON (45802-706-94) / 30 g in 1 TUBE |
| 45802-706-96 | 45802-706 | HUMAN PRESCRIPTION DRUG | TAZAROTENE | tazarotene | CREAM | TOPICAL | 20240909 | N/A | ANDA | ANDA217075 | Padagis Israel Pharmaceuticals Ltd | TAZAROTENE | .5 mg/g | 1 TUBE in 1 CARTON (45802-706-96) / 60 g in 1 TUBE |